Navigation Links
Haemacure financing receives shareholder consent - Series B Warrants are amended
Date:5/14/2008

he Schedule annexed to this press release sets out: (a) the names and positions of the "insiders" who hold Series B Warrants; and (b) assuming such "insiders" exercise all Series B Warrants and additional warrants held by them, the number and percentage of common shares of Haemacure that each will own.

About Haemacure

Haemacure Corporation is a specialty biotherapeutics company developing high-value human plasma-derived protein products for commercialization. Haemacure's research and development effort is driven by its proprietary plasma protein extraction technology to develop next-generation products, including surgical hemostats. Haemacure's lead product candidate, Hemaseel(R)HMN, is a fibrin sealant to enter pivotal Phase II/Phase III clinical trials during the first quarter of 2009. Haemacure's second product candidate is thrombin, a component of its fibrin sealant, now in preclinical stage. Follow-on development will focus on surgical hemostats, wound healing, adhesion prevention, regenerative medicine, drug delivery and combinations with biomaterials. Haemacure has discovered eleven additional specialty proteins and enzymes in one of its two plasma fractions and seeks to advance these proteins and enzymes through partnerships with pharmaceutical and biotechnology companies. Haemacure operates offices in Sarasota, Florida through a wholly-owned subsidiary. The Corporation is traded under stock symbol HAE on the TSX.

Forward-looking Statements

Certain of the statements contained in this news release are forward-looking statements. Such statements, based as they are on the current expectations of management, inherently involve numerous risks and uncertainties, known and unknown. Some examples of known risks are: the impact of general economic conditions, general conditions in the biotech industry, changes in the regulatory environment in the jurisdictions in which Haemacure does business, stock market volatility, fluctuations in costs
'/>"/>

SOURCE HAEMACURE CORPORATION
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Haemacure to Present at the BioFinance 2008 Conference to be held at the Toronto Marriott Eaton Centre, May 6 - 8, 2008
2. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
3. Haemacure Reports on its annual general and special meeting of shareholders
4. Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure
5. Haemacure Announces Details of its Annual General and Special Meeting of Shareholders
6. Haemacure announces webcast of presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conferencec
7. Haemacure Adopts Strategy for "First-Patient-In" Fibrin Sealant Pivotal Clinical Trials
8. Haemacure Reports Third Quarter 2007 Results
9. InfoLogix Completes $25 Million Senior Debt Financing
10. Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing
11. Astute Medical Raises $6.2 Million in Series A Financing Round Led by De Novo Ventures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 Great defined abs are the ... everyone strives to achieve in the gym yet so many ... not make this goal become a reality. Great abdominal muscles ... often time overlooked. Scott Tischler of Tischler Brothers Fitness explains ... achieve the goal of great abs. , 1.    Go to bed ...
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 Footwear etc. ... Dansko Vista Collection of sandals containing cork footbeds. Known ... has had consistently good sales for many years, and with ... spring and summer. , Dansko Shoes and ... the Vista Collection is no exception. Containing leather and patent ...
(Date:5/23/2013)... Shirataki noodles are growing in ... a diet strategy. These noodles are originally from Japan ... When losing weight, diet and exercise are the two ... dieters not only research shirataki noodles but offers tons ... buy them. Shirataki noodles are very healthy ...
(Date:5/23/2013)... GBI Research’s analysis indicates that the global ... small number of players accounting for a major proportion of ... growth rate between 2006 and 2012, possibly due to the ... markets, especially in the US. , GBI Research estimates ... billion in 2012, having grown in size at a CAGR ...
(Date:5/22/2013)... 2013 Catalyst Exhibits, Inc., an award-winning ... feature to its website that allows visitors to ... through an immersive, 360-degree, interactive experience. , The ... ability to virtually experience the exhibit design Catalyst created ... and services. Users have the ability to interact with ...
Breaking Medicine News(10 mins):Health News:Scott Tischler of Tischler Brothers Fitness Unveils the 4 Secrets to Getting Abs this Summer 2Health News:Footwear etc. Announces the New Collection of Dansko Cork Sandals 2Health News:DietNoodleShop.com is Re-launching; Adding More Diet Recipes Along with Information on Shirataki Noodles 2Health News:MarketResearch.com Report – Increased Cost of Albumin was Main Factor for Double-Digit Growth of Global Critical Care Market Between 2006 and 2012 2Health News:Catalyst Exhibits Debuts 360 Degree Virtual Tour of St. Jude Medical Trade Show Booth 2
... claimed that they have developed a vaccine against two ... question can easily kill humans and could potentially be ... viruses is that Hendra virus emerged in 1994, killing ... in Brisbane. Thereafter the trainer of Vo Rogue, died ...
... study has now proved that acupuncture, even sham acupuncture may ... migraine//. A comparable level of treatment efficacy has been documented ... with respect to reduction in migraine days. ,More ... for the study. The study participants who had two to ...
... investigate the possibility of building the labs across the world ... to invest $1.9bn from various developed countries where the investigation ... ,Tony Blair while facing questions in the House of Commons ... insisted that precautions were adequate. He proposed to set up ...
... the University of California, Irvine (UCI) and also the ... drug// AF267B is effective against both forms of brain ... ,This compound (AF267B) curbs both the amyloid protein plaques ... lesion, the tangles of protein called tau. ...
... Cancer researcher Philippa Darbre, PhD, of the University of Reading ... the use of deodorants or antiperspirants and breast cancer. She ... mimics estrogen in the body.// ,"Lifetime exposure to ... to breast cancer," Darbre said. "If the aluminum salts in ...
... bewildered as about 3,000 people in the steel town were affected ... reported in a small group at a slum// cluster in Panposh ... Since then, it has rapidly spread to other parts of the ... and acute colic pain, said a senior district health official. ...
Cached Medicine News:Health News:Experimental Alzheimer’s Drug curbs the disease in mic 2
(Date:5/22/2013)... N.Y. , May 22, 2013  MGT Capital ... Company will present at the Second Annual Marcum LLP ... New York City at the Grand ... and Chief Executive Officer, will update investors and answer ... The Company,s presentation is scheduled to begin at ...
(Date:5/22/2013)... May 22, 2013   Life Line Screening ... announced today the creation of a unique partnership with ... MCM is a population health management organization. ... list of clients. These important expanded services will help ... earlier. Effective prevention reduces cost of care when individuals ...
(Date:5/22/2013)... CAMBRIDGE, Mass. , May 22, 2013 /PRNewswire/ ... creation firm focused on healthcare and sustainability, today ... as a Senior Partner. In this ... support to portfolio companies. In addition ... portfolio, Mr. Bancel also serves as President and ...
Breaking Medicine Technology:MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3
... N.J., Jan. 3, 2012  Ikaria, Inc., a critical care ... critically ill patients in the hospital and ICU settings, ... program, the PRESERVATION I clinical trial, for its Bioabsorbable ... commenced in Australia, and will be followed in Europe.  ...
... 3, 2012 Reportlinker.com announces that a ... its catalogue: Transdermal Drug ... http://www.reportlinker.com/p0203552/Transdermal-Drug-Delivery---Technologies-Markets-and-Companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... -Up-to-date one-stop information on transdermal drug ...
Cached Medicine Technology:Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix 2Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix 3Transdermal Drug Delivery - Technologies, Markets, and Companies 2Transdermal Drug Delivery - Technologies, Markets, and Companies 3Transdermal Drug Delivery - Technologies, Markets, and Companies 4Transdermal Drug Delivery - Technologies, Markets, and Companies 5Transdermal Drug Delivery - Technologies, Markets, and Companies 6Transdermal Drug Delivery - Technologies, Markets, and Companies 7Transdermal Drug Delivery - Technologies, Markets, and Companies 8Transdermal Drug Delivery - Technologies, Markets, and Companies 9Transdermal Drug Delivery - Technologies, Markets, and Companies 10Transdermal Drug Delivery - Technologies, Markets, and Companies 11
The 920M PLUS handheld pulseoximeter provides on-the-spot bloodoximetry and heart rate readings....
Rad-5 signal extraction pulse oximeter™...
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
The pocket-size Invacare Digit finger pulse oximeter is a convenient and economical solution to fast, reliable SpO2, pulse rate and pulse strength measurements. Its compact size is ideal for home use...
Medicine Products: